Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • UK plans to cut pipelines to EU if Russia gas crisis intensifies
    • Ghislaine Maxwell sidesteps responsibility in sentencing comments
    • US to boost Europe military presence as Nato strengthens defences
    • Finland and Sweden poised to join Nato after Turkey drops veto
    • Dramatic testimony sheds damning light on Donald Trump’s actions on January 6
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • The risk of a flip-flopping Fed
    • US to boost Europe military presence as Nato strengthens defences
    • Dramatic testimony sheds damning light on Donald Trump’s actions on January 6
    • Finland and Sweden poised to join Nato after Turkey drops veto
    • Meta sparks anger by charging for VR apps
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Mukesh Ambani prepares to hand Reliance empire to his children
    • Blackstone dealt legal setback after $5bn low-income housing deal
    • Hong Kong elite descends on Tokyo for bargain property buys
    • Lloyds reshuffles bankers as part of chief’s new strategy
    • German arms companies fear for their slice of defence windfall
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates from June 29: Central bank chiefs call end to era of low rates, US indicates new openness to selling Turkey upgraded F-16s
    • Live news updates: Gazprom shares fall 25% as dividend is blocked
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • Value in the short(er) end
    • UK energy regulator to limit profits at electricity distributors
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The risk of a flip-flopping Fed
    • The 30-year-old comic book that became a Silicon Valley bible
    • Monkeypox makes pledges of pandemic solidarity look hollow
    • Are we protecting airlines from their own shortcomings?
    • Childcare is a looming political battle that is long overdue
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • What’s a good (and bad) way to leave your job?
    • How can I move from being a specialist police detective to financial services?
    • If you want to be more likeable, try showing more stress
    • ‘Exactly how much virtue do you really want to signal?’
    • JSR’s Eric Johnson: ‘I encourage people to tell me exactly how they think’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Inside the secret, often bizarre world that decides what porn you see
    • The 30-year-old comic book that became a Silicon Valley bible
    • The fixer, the cheat and the corruption crisis in global tennis
    • At home with Champagne Charlie
    • Ibiza — for a city break?
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Moderna

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Wednesday, 22 June, 2022
    Moderna calls for approval of two-strain Covid vaccine booster

    US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases

  • Wednesday, 22 June, 2022
    Covid-19 vaccines
    UK signs £1bn deal with Moderna for new vaccine centre

    Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech

  • Wednesday, 15 June, 2022
    Covid-19 vaccines
    FDA advisory panel backs Covid-19 vaccines for children under 5

    US prepares to roll out jabs to last age group without access once regulatory approval is received

  • Wednesday, 8 June, 2022
    Covid-19 vaccines
    Moderna reports positive data for new Covid booster targeting Omicron variant

    US pharma company aims to roll out the new vaccine by late summer

  • Wednesday, 18 May, 2022
    Interview
    Moderna chair defends executive hiring process after CFO fiasco

    Top finance director ousted after one day in job following emergence of probe at former employer

  • Saturday, 14 May, 2022
    News in-depth
    Moderna CFO’s departure reignites debate over company’s culture

    Exit of Jorge Gomez after only a day in the job is latest in string of executives to leave biotech group

  • Wednesday, 11 May, 2022
    Moderna’s new CFO departs in first week in job

    Jorge Gomez leaves vaccine maker after former employer launches probe into financial reporting

  • Wednesday, 4 May, 2022
    Moderna targets autumn release for Omicron vaccine

    US drugmaker says demand for ‘bivalent booster’ could lift jab sales in second half of 2022

  • Wednesday, 27 April, 2022
    Moderna investors reject proposal to transfer vaccine tech

    Two top-10 shareholders say distribution problems not supply is reason for slower vaccination rates in low-income countries

  • Friday, 22 April, 2022
    The Top LineTom Braithwaite
    ‘We are drowning in vaccine.’ What will revive the market for Covid jabs?

    Moderna’s chief says there is ‘massive oversupply’

  • Tuesday, 19 April, 2022
    Covid-19 vaccines
    Moderna and Pfizer urged to share vaccine technology with developing world

    Proxy advisers back shareholder resolutions as new shot shows promising results

  • Tuesday, 5 April, 2022
    Pfizer Inc
    Chief executives of mRNA vaccine groups earned $100mn in pandemic pay

    Remuneration at the three big jab makers reflects surge in value of share options

  • Wednesday, 23 March, 2022
    Covid-19 vaccines
    Moderna to seek emergency approval for Covid vaccine for children under 6

    Drugmaker says jab is safe and boosts immunity but had modest efficacy against Omicron

  • Tuesday, 8 March, 2022
    Covid-19 vaccines
    Moderna vows never to enforce Covid jab patents in policy U-turn

    Switch in US company’s stance follows criticism over vaccine inequality in low- and middle-income nations

  • Thursday, 24 February, 2022
    Covid-19 vaccines
    Moderna says pandemic will end in 2022 but annual boosters needed

    US drugmaker reports first annual profit and rejects concerns it is a ‘one product company’

  • Friday, 18 February, 2022
    Moral Money
    The growing power of shareholder proposals Premium content

    Plus, renewed legal action over sustainability claims and a stark reversal of fortunes for European wind groups

  • Wednesday, 16 February, 2022
    Trade SecretsAlan Beattie
    A Covid vaccine breakthrough bypasses the stale debate on patent waivers

    Fractious World Trade Organization talks on overriding intellectual property rights look increasingly irrelevant

  • Thursday, 6 January, 2022
    Covid-19 vaccines
    Covid vaccine makers face investor pressure over global access

    Asset managers call for pharma executive pay to be linked to equitable distribution of jabs

  • Sunday, 26 December, 2021
    Covid-19 vaccines
    Moderna faces shareholder pressure over cost of vaccine

    Activists and politicians push pharma company to cut prices and expand production for poorer countries

  • Thursday, 23 December, 2021
    News in-depthMedical science
    Covid vaccine winners set sights on flu as their next big target

    New mRNA technology could make jabs better-matched to different annual strains and improve efficacy

  • Monday, 20 December, 2021
    Covid-19 vaccines
    Moderna Covid booster produces strong antibody response against Omicron

    Half a dose lifts levels to 37 times higher than immune response after two doses

  • Thursday, 2 December, 2021
    Covid-19 vaccines
    UK’s ‘mix and match’ booster jab strategy backed by new study

    Research shows mRNA vaccines from Pfizer and Moderna are by far most effective third doses

  • Tuesday, 30 November, 2021
    Covid-19 vaccines
    Vaccine makers split on protection against Omicron variant

    WHO says differing predictions from Oxford, BioNTech and Moderna are ‘premature’

  • Tuesday, 30 November, 2021
    InterviewCovid-19 vaccines
    Moderna chief predicts existing vaccines will struggle with Omicron

    Stéphane Bancel foresees ‘material drop’ in current jabs’ effectiveness, sending stocks and oil prices lower

  • Monday, 29 November, 2021
    LexCovid-19 vaccines
    Omicron vaccines: booster shots will boost the mRNA pioneers Premium content

    Combating coronavirus could end up resembling a game of whack-a-mole

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In